DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance

BACKGROUND: Hypoxia is pervasive in cancer and other diseases. Cells sense and adapt to hypoxia by activating hypoxia-inducible transcription factors (HIFs), but it is still an outstanding question why cell types differ in their transcriptional response to hypoxia. RESULTS: We report that HIFs fail...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Anna, Flora, Van Dyck, Laurien, Xiong, Jieyi, Zhao, Hui, Berrens, Rebecca V., Qian, Junbin, Bieniasz-Krzywiec, Pawel, Chandra, Vikas, Schoonjans, Luc, Matthews, Jason, De Smedt, Julie, Minnoye, Liesbeth, Amorim, Ricardo, Khorasanizadeh, Sepideh, Yu, Qian, Zhao, Liyun, De Borre, Marie, Savvides, Savvas N., Simon, M. Celeste, Carmeliet, Peter, Reik, Wolf, Rastinejad, Fraydoon, Mazzone, Massimiliano, Thienpont, Bernard, Lambrechts, Diether
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384226/
https://www.ncbi.nlm.nih.gov/pubmed/32718321
http://dx.doi.org/10.1186/s13059-020-02087-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384226/
https://www.ncbi.nlm.nih.gov/pubmed/32718321
http://dx.doi.org/10.1186/s13059-020-02087-z

Ejemplares similares